Abstract
Breast cancer occurs in about 1% of men, but the number of men receiving a diagnosis is increasing. Data on male breast cancer (MBC) is limited, and treatment for men is based primarily on treatments used for women. However, some argue that breast cancer in men is a different disease than breast cancer in women. Multiple risk factors, including those with genetic and environmental origins, affect the likelihood of men receiving a breast cancer diagnosis. This article discusses types of MBC, risk factors, treatment options, and ethical concerns men encounter after they receive a breast cancer diagnosis.
© 2019 American Society of Radiologic Technologists.
MeSH terms
-
Biopsy
-
Breast / anatomy & histology
-
Breast Neoplasms, Male / diagnosis*
-
Breast Neoplasms, Male / metabolism
-
Breast Neoplasms, Male / therapy*
-
Carcinoma, Ductal, Breast / diagnosis
-
Carcinoma, Ductal, Breast / therapy
-
Carcinoma, Intraductal, Noninfiltrating / diagnosis
-
Carcinoma, Intraductal, Noninfiltrating / therapy
-
Genetic Predisposition to Disease
-
Humans
-
Inflammatory Breast Neoplasms / diagnosis
-
Inflammatory Breast Neoplasms / therapy
-
Magnetic Resonance Imaging
-
Male
-
Mammography
-
Neoplasm Staging
-
Occupational Exposure / adverse effects
-
Prognosis
-
Receptor, ErbB-2 / metabolism
-
Risk Factors
-
Transgender Persons
Substances
-
ERBB2 protein, human
-
Receptor, ErbB-2